1-[1-hydrazinyl-2-(2-propyl-1,2,4-triazol-3-yl)ethyl]-N,N-dimethylcyclohexan-1-amine
C15H30N6 — CID 105243326
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[1-hydrazinyl-2-(2-propyl-1,2,4-triazol-3-yl)ethyl]-N,N-dimethylcyclohexan-1-amine
1-[1-hydrazinyl-2-(2-propyl-1,2,4-triazol-3-yl)ethyl]-N,N-dimethylcyclohexan-1-amine (PubChem CID 105243326) has the molecular formula C15H30N6 and a molecular weight of 294.45 g/mol. Its IUPAC name is 1-[1-hydrazinyl-2-(2-propyl-1,2,4-triazol-3-yl)ethyl]-N,N-dimethylcyclohexan-1-amine.
Molecular Properties
| Compound Name | 1-[1-hydrazinyl-2-(2-propyl-1,2,4-triazol-3-yl)ethyl]-N,N-dimethylcyclohexan-1-amine |
|---|---|
| PubChem CID | 105243326 |
| Molecular Formula | C15H30N6 |
| Molecular Weight | 294.45 g/mol |
| Exact Mass | 294.25 |
| IUPAC Name | 1-[1-hydrazinyl-2-(2-propyl-1,2,4-triazol-3-yl)ethyl]-N,N-dimethylcyclohexan-1-amine |
| SMILES | CCCn1ncnc1CC(NN)C1(N(C)C)CCCCC1 |
| InChI | InChI=1S/C15H30N6/c1-4-10-21-14(17-12-18-21)11-13(19-16)15(20(2)3)8-6-5-7-9-15/h12-13,19H,4-11,16H2,1-3H3 |
| InChIKey | AHDFCYWJAYWJAF-UHFFFAOYSA-N |
| XLogP | 1.33 |
| TPSA | 72.00 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 294.45 |
| LogP ≤ 5 | 1.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 105243326 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.